期刊
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
卷 7, 期 1, 页码 82-85出版社
OXFORD UNIV PRESS
DOI: 10.1093/jpids/pix005
关键词
adverse events; immunogenicity; pentavalent vaccine; rotavirus; safety
资金
- Merck Investigator Studies Program
- Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [5T32HD060558]
This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an alternative schedule (initiated at 2-5 weeks of age) with those of RV5 administered on the recommended standard schedule. Our findings support the future conduct of larger clinical trials to confirm the safety and efficacy of rotavirus vaccination in the neonatal period.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据